YD Bio Ltd (YDES) Cash Flow Statement
YD Bio Ltd (YDES) generated -$7.3M of operating cash flow over the twelve months to 2026-06-30, spent $1.4M on capital expenditure and had free cash flow of -$8.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
YDESYD Bio LtdFollow YDES — free
—
Price chart with a free account
- Market cap
- 350.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- —
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Operating cash flow | -0.1 | -1.2 | -6.6 | -7.3 | |
| Capital expenditure | 0.0 | 0.1 | 1.4 | -1.4 | |
| Free cash flow | -0.1 | -1.3 | -8.0 | -8.7 |
USD millions · SEC XBRL
YD Bio Ltd — questions
- What is YD Bio Ltd's operating cash flow?
- -$7.3M over the twelve months to 2026-06-30.
- How much does YD Bio Ltd spend on capital expenditure?
- $1.4M over the twelve months to 2026-06-30.
- What is YD Bio Ltd's free cash flow?
- -$8.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from YD Bio Ltd's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.